Free Trial

Kodiak Sciences (KOD) Insider Trading & Ownership

Kodiak Sciences logo
$8.65 -0.03 (-0.35%)
(As of 12/20/2024 05:45 PM ET)

Kodiak Sciences (NASDAQ:KOD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
45.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$12,452.86
Get KOD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kodiak Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KOD Insider Buying and Selling by Quarter

Kodiak Sciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/17/2024John A BorgesonInsiderSell2,874$2.75$7,903.50  
6/12/2024John A BorgesonInsiderSell1,558$2.92$4,549.36  
(Data available from 1/1/2013 forward)

KOD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Kodiak Sciences includes Bros. Advisors Lp Baker, Jason Ehrlich, John A Borgeson, and Victor Perlroth. Learn more on insiders at KOD.

45.30% of Kodiak Sciences stock is owned by insiders. Learn more on KOD's insider holdings.

The following insiders have sold KOD shares in the last 24 months: Jason Ehrlich ($31,504.78), and John A Borgeson ($12,452.86).

Insiders have sold a total of 7,822 Kodiak Sciences shares in the last 24 months for a total of $43,957.64 sold.

Kodiak Sciences Key Executives

  • Dr. Victor Perlroth M.D. (Age 51)
    Co-Founder, Chairman, CEO & President
    Compensation: $1.08M
  • Mr. John A. Borgeson CPAMr. John A. Borgeson CPA (Age 62)
    M.B.A., Senior VP, CFO & Secretary
    Compensation: $667.52k
  • Dr. Michael S. Louie Ph.D.
    Senior VP of Digital Transformation & Chief Information Officer
  • Dr. Hong Liang (Age 52)
    Senior Vice President of Discovery Medicine
    Compensation: $300.71k
  • Dr. Stephen Raillard Ph.D.
    Senior Vice President of Chemical Development & Manufacturing
  • Ms. Almas Qudrat M.Sc.
    Senior Vice President of Quality Operations
  • Dr. J. Pablo Velazquez-Martin M.D.
    Senior VP of Clinical Research & Development
  • Tracy Chien
    VP & Corporate Controller


This page (NASDAQ:KOD) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners